Article

ASCRS 2020: Evaluation of intraoperative use of DEXYCU on signs/symptoms of dry eye

Sanjay N. Rao, MD, director of Refractive, Cornea and Advanced Anterior Segment Surgery at Dekalb Eye Consultants LLC, speaks with Ophthalmology Times' David Hutton on his presentation "Evaluation of intraoperative use of dexamethasone intraocular suspension, 9% (DEXYCU) on signs and symptoms of dry eye," during the 2020 ASCRS virtual conference.

 

See more ASCRS coverage here 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.